Successful treatment of monoclonal, aggressive Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a child with acute lymphoblastic leukemia

Med Pediatr Oncol. 1999 Jun;32(6):447-9. doi: 10.1002/(sici)1096-911x(199906)32:6<447::aid-mpo12>3.0.co;2-1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antiviral Agents / therapeutic use
  • Child
  • Herpesvirus 4, Human* / genetics
  • Herpesvirus 4, Human* / isolation & purification
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / virology*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell / virology*
  • Male
  • Mercaptopurine / adverse effects
  • Methotrexate / adverse effects
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Antiviral Agents
  • Immunosuppressive Agents
  • Mercaptopurine
  • Methotrexate